Traders Purchase High Volume of Put Options on Becton Dickinson and (NYSE:BDX)

Becton Dickinson and Co (NYSE:BDX) saw unusually large options trading activity on Thursday. Stock investors bought 3,541 put options on the company. This is an increase of approximately 707% compared to the average daily volume of 439 put options.

A number of equities analysts recently commented on the stock. Wells Fargo & Co reissued a “buy” rating on shares of Becton Dickinson and in a research note on Friday, May 8th. Barclays reissued a “hold” rating and issued a $266.00 price objective on shares of Becton Dickinson and in a research note on Tuesday, April 14th. Stifel Nicolaus boosted their price objective on shares of Becton Dickinson and from $265.00 to $280.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Cowen downgraded Becton Dickinson and from an “outperform” rating to a “market perform” rating and reduced their price target for the stock from $306.00 to $275.00 in a research report on Thursday, February 6th. Finally, Piper Sandler upped their price target on Becton Dickinson and from $286.00 to $296.00 and gave the stock an “overweight” rating in a research report on Thursday, May 14th. Nine equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $275.79.

NYSE BDX opened at $239.25 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.98 and a quick ratio of 0.66. The stock’s fifty day moving average price is $253.35 and its 200 day moving average price is $255.35. Becton Dickinson and has a 1 year low of $197.75 and a 1 year high of $286.72. The company has a market cap of $64.79 billion, a price-to-earnings ratio of 72.06, a PEG ratio of 2.57 and a beta of 0.95.

Becton Dickinson and (NYSE:BDX) last released its earnings results on Thursday, May 7th. The medical instruments supplier reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.32 by $0.23. Becton Dickinson and had a return on equity of 15.75% and a net margin of 6.10%. The firm had revenue of $4.25 billion for the quarter, compared to the consensus estimate of $4.10 billion. During the same period in the prior year, the firm earned $2.59 EPS. The firm’s revenue was up 1.4% on a year-over-year basis. Research analysts expect that Becton Dickinson and will post 10.5 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 9th will be given a $0.79 dividend. This represents a $3.16 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Monday, June 8th. Becton Dickinson and’s payout ratio is 27.05%.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company increased its position in shares of Becton Dickinson and by 16.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 490,271 shares of the medical instruments supplier’s stock valued at $112,650,000 after acquiring an additional 70,405 shares during the period. Odey Asset Management Group Ltd purchased a new stake in Becton Dickinson and in the first quarter valued at $1,723,000. FDx Advisors Inc. boosted its holdings in Becton Dickinson and by 23.1% in the first quarter. FDx Advisors Inc. now owns 4,364 shares of the medical instruments supplier’s stock valued at $1,003,000 after purchasing an additional 820 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in Becton Dickinson and by 233.2% in the first quarter. Clearbridge Investments LLC now owns 1,443,571 shares of the medical instruments supplier’s stock valued at $331,689,000 after purchasing an additional 1,010,279 shares during the last quarter. Finally, Cim Investment Mangement Inc. boosted its holdings in Becton Dickinson and by 3.3% in the first quarter. Cim Investment Mangement Inc. now owns 2,736 shares of the medical instruments supplier’s stock valued at $629,000 after purchasing an additional 87 shares during the last quarter. 86.79% of the stock is currently owned by hedge funds and other institutional investors.

Becton Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems.

See Also: Understanding the different types of bonds

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.